期刊
JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY
卷 62, 期 2, 页码 114-139出版社
WILEY
DOI: 10.1111/jcpp.13262
关键词
Generalized anxiety disorder; separation anxiety disorder; fMRI; pharmacogenomics; selective serotonin reuptake inhibitor (SSRI; SRI)
资金
- Eunice Kennedy Shriver National Institute of Child Health and Development (NICHD) [R01HD098757]
- Yung Family Foundation
- National Institutes of Health (NIMH/NIEHS/NICHD)
- Allergan
- Otsuka
- Chinese Government Scholarship
- National Institutes of Health (NICHD)
- NIMH
- Tourette Syndrome Association of America
- Hartwell Foundation
- Tourette Association of America
- Neuronetics
Anxiety disorders are common, early-onset conditions with various risk factors and are effectively treated with cognitive behavioral therapy, selective serotonin reuptake inhibitors, and serotonin-norepinephrine reuptake inhibitors. The disorders are associated with distinct neurobiological features and show consistent response to treatment, although questions remain about risk factors and neurobiology's impact on treatment outcomes.
Background Anxiety disorders first emerge during the critical developmental periods of childhood and adolescence. This review synthesizes recent findings on the prevalence, risk factors, and course of the anxiety disorders; and their neurobiology and treatment. Methods For this review, searches were conducted using PubMed, PsycINFO, and . Findings related to the epidemiology, neurobiology, risk factors, and treatment of pediatric anxiety disorders were then summarized. Findings Anxiety disorders are high prevalence, and early-onset conditions associated with multiple risk factors including early inhibited temperament, environment stress, and structural and functional abnormalities in the prefrontal-amygdala circuitry as well as the default mode and salience networks. The anxiety disorders are effectively treated with cognitive behavioral therapy (CBT), selective serotonin reuptake inhibitors (SSRIs), and serotonin-norepinephrine reuptake inhibitors (SNRIs). Conclusions Anxiety disorders are high prevalence, early-onset conditions associated with a distinct neurobiological fingerprint, and are consistently responsive to treatment. Questions remain regarding who is at risk of developing anxiety disorders as well as the way in which neurobiology predicts treatment response.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据